<DOC>
	<DOCNO>NCT02250820</DOCNO>
	<brief_summary>The study examine quality two sedation technique ( dexmedetomidine pentobarbital ) use child age 3 24 month undergo transthoracic echocardiography ( TTE ) .</brief_summary>
	<brief_title>A Comparison Two Sedation Techniques Children Undergoing Transthoracic Echocardiography ( TTE )</brief_title>
	<detailed_description>Currently two sedation method use child less 24 month age undergoing transthoracic echocardiography ( TTE ) . - One method provide sedation mouth drug pentobarbital , - The provide sedation nose drug dexmedetomidine . The choice method use base evaluation patient 's medical history preference anesthesiologist . To knowledge , study compare two sedation technique quality care . The propose study help u determine method yield best quality allow u improve healthcare experience patient .</detailed_description>
	<mesh_term>Heart Diseases</mesh_term>
	<mesh_term>Dexmedetomidine</mesh_term>
	<mesh_term>Pentobarbital</mesh_term>
	<criteria>Outpatients , schedule receive sedation elective transthoracic echocardiography The subject must candidate anesthetic technique . A staff member Division Cardiac Anesthesiology make decision . The subject must 3 month 24 month ( inclusive 24th month ) . The subject 's legally authorize representative give write informed consent participate study . The subject history cardiac conduction system disease ( e.g . 1st 2nd degree Atrioventricular block ) channelopathy ( e.g . long QT syndrome ) . The subject take digoxin , alphaadrenergic betaadrenergic agonist antagonist ( e.g. , clonidine , propranolol , albuterol ) , antiarrhythmic medication , vasodilator ( e.g . ACE inhibitor ) day study procedure . It routine child take medication hold day procedure , request clinical team . The subject receive dose sedative within 48 hour . The subject lifethreatening , medical condition ( American Society Anesthesiologists Physical Status 4 , 5 ) . The American Society Anesthesiologists ( ASA ) classification scale measure physical status healthy patient . For study , focus child define ASA I , II III mean healthy child ( ASA I ) , child systemic disease mild well control ( ASA II ) child systemic disease severe control ( ASA III ) . The subject allergic contraindication drug mask flavor syrup use study . The subject previously treat protocol . The subject Trisomy 21 ( exaggerate risk bradycardia ) The subject severe coarctation aorta ( risk exaggerate vasoconstriction ) The subject Moyamoya disease ( risk recurrent stroke )</criteria>
	<gender>All</gender>
	<minimum_age>3 Months</minimum_age>
	<maximum_age>24 Months</maximum_age>
	<verification_date>August 2016</verification_date>
	<keyword>Pediatric</keyword>
	<keyword>Sedation</keyword>
	<keyword>Transthoracic echocardiography</keyword>
	<keyword>TTE</keyword>
	<keyword>Dexmedetomidine</keyword>
	<keyword>Pentobarbital</keyword>
</DOC>